Utilizing Nanoencapsulated Cannabinoid Therapies for Chronic Treatment of Opiod Use Disorder

• Formulation to support the translation of cannabinoid – based therapies from acute to chronic therapeutic use
• Discussing the development of a combined CBD and naltrexone formulation designed to enhance efficacy and patient compliance in treating opioid use disorder
• Investigating the sustainability advantages of utilizing CO2 in the nanoencapsulation manufacturing process

NEW DATA